Menu

Blog

Archive for the ‘biotech/medical’ category: Page 359

Dec 8, 2023

Molecular Toxicology and Cancer Prevention

Posted by in categories: biotech/medical, chemistry

📾 Look at this post on Facebook https://m.facebook.com/story.php?story_fbid=863605902432876&
tid=CDWPTG


Molecular toxicology is a field that investigates the interactions between chemical or biological molecules and organisms at the molecular level. In this Special Issue, we focus on the toxic effects and mechanisms of action of chemical and biological molecules, will be of great interest of readers in molecular toxicology and applied pharmacology.

Dec 8, 2023

Rosacea: Diagnosis, Treatment, and Steps to Take

Posted by in categories: biotech/medical, health

Rosacea is a skin condition that causes reddened skin and rash, usually on the nose and cheeks. There is no test for rosacea, so health care providers will typically diagnose it based on the appearance of the skin and your health history. They may run tests to rule out any other conditions. Learn more from NIAMS:


What is rosacea? It is a long-term disease that causes reddened skin and pimples, usually on the face. It can also make the skin thicker and cause eye problems.

Dec 7, 2023

Double-Limb Graft Versus Single-Limb Graft Medial Patellofemoral Ligament Reconstruction for Recurrent Patellar Dislocation: A Meta-analysis of Randomized Controlled Trials and Cohort Studies — Long Pang

Posted by in category: biotech/medical

The medial patellofemoral ligament (MPFL) is the most important stabilizer of lateral dislocation of the patella. Single-limb (SL) and double-limb (DL) graft MPFL reconstructions have been increasingly used to treat recurrent patellar dislocations, but the clinical efficacy of SL versus DL graft MPFL reconstructions remains controversial owing to the inconsistent conclusions of previous studies.

Dec 7, 2023

Biological Immortality by 2030: Implications & Predictions

Posted by in categories: biotech/medical, life extension

The concept of biological immortality challenges the belief that death gives meaning to life and raises questions about the potential societal implications and ethical considerations of living indefinitely.

Questions to inspire discussion.

Continue reading “Biological Immortality by 2030: Implications & Predictions” »

Dec 7, 2023

Unlocking the Power of Neuroplasticity: Transforming Your Brain for Lifelong Growth

Posted by in categories: biotech/medical, neuroscience

The Sentis Brain Animation Series takes you on a tour of the brain through a series of short and sharp animations. The fourth in the series explains how our most complex organ is capable of changing throughout our lives. This inspiring animation demonstrates how we all have the ability to learn and change by rewiring our brains. Who is Sentis? We are a global team assisting individuals and organisations change their lives for the better. The human mind is our focus and we believe the mind is an individual’s most important performance tool. We are the world leaders in the application of psychology and neuroscience to safety, leadership development, and wellbeing in the workplace. The Sentis Brain Animation Series is the intellectual property of Sentis Pty Ltd and only approved for third party use under a formal licensing agreement.

Dec 7, 2023

AI opens a path to a better understanding of changes in the brain

Posted by in categories: biotech/medical, robotics/AI

Brain networks are often represented by graph models that incorporate neuroimaging data from MRI or CT scans to represent functional or structural connections within the brain. These brain graphs can be used to understand how the organ changes over time.

Traditionally, however, these models treat the brain graphs as static, which can miss or ignore underlying changes that could signal the onset of disease or neurological disorders.

A collaborative team of researchers led by Lifang He, an assistant professor of computer science and engineering at Lehigh University, recently received a $1 million grant from the National Science Foundation, with $300,000 going to Lehigh, to develop new methods for modeling the dynamics of brain graphs using artificial intelligence that will generate more accurate, interpretable, and fair predictions when it comes to disease.

Dec 7, 2023

Laser Leap: Organic Breakthrough Lights Up the Tech World

Posted by in categories: biotech/medical, innovation

Scientists have made a pivotal advancement in creating compact laser technology using organic semiconductors. This development promises diverse applications, from enhancing OLED displays to aiding in disease detection and environmental monitoring. The new laser, which emits green light in short pulses, overcomes the traditional need for an external laser in organic semiconductor lasers. Credit: SciTechDaily.com.

Scientists have achieved a breakthrough in creating an electrically driven organic semiconductor laser, paving the way for advanced and versatile laser applications.

Researchers at the University of St. Andrews are leading a significant breakthrough in a decades-long challenge to develop compact laser technology.

Dec 7, 2023

Redefining Brain Evolution: Unveiling the “Little Brain’s” Role in the Human Cognitive Leap

Posted by in categories: biotech/medical, evolution, genetics, neuroscience

The advancement of higher cognitive abilities in humans is predominantly associated with the growth of the neocortex, a brain area key to conscious thinking, movement, and sensory perception. Researchers are increasingly realizing, however, that the “little brain” or cerebellum also expanded during evolution and probably contributes to the capacities unique to humans, explains Prof. Henrik Kaessmann from the Center for Molecular Biology of Heidelberg University.

His research team has – together with Prof. Dr Stefan Pfister from the Hopp Children’s Cancer Center Heidelberg – generated comprehensive genetic maps of the development of cells in the cerebella of humans, mice, and opossums. Comparisons of these data reveal both ancestral and species-specific cellular and molecular characteristics of cerebellum development spanning over 160 million years of mammalian evolution.

Dec 7, 2023

Rising colorectal cancer risk in young adults calls for earlier screening, study suggests

Posted by in category: biotech/medical

đŸŽ—ïž 📊 🔬


Study reveals an increase in adenomas and advanced adenomas in younger adults, alongside a rise in colorectal cancer incidence in males under 50, suggesting a need for earlier screening, particularly in men.

Dec 7, 2023

The Virus Zoo: A Primer on Molecular Virology

Posted by in categories: biotech/medical, genetics

Genome and Structure:

HIV’s genome is a 9.7 kb linear positive-sense ssRNA.1 There is a m7G-cap (specifically the standard eukaryotic m7GpppG as added by the host’s enzymes) at the 5’ end of the genome and a poly-A tail at the 3’ end of the genome.2 The genome also has a 5’-LTR and 3’-LTR (long terminal repeats) that aid its integration into the host genome after reverse transcription, that facilitate HIV genetic regulation, and that play a variety of other important functional roles. In particular, it should be noted that the integrated 5’UTR contains the HIV promoter called U3.3,4

HIV’s genome translates three polyproteins (as well as several accessory proteins). The Gag polyprotein contains the HIV structural proteins. The Gag-Pol polyprotein contains (within its Pol component) the enzymes viral protease, reverse transcriptase, and integrase. The Gag-Pol polyprotein is produced via a −1 ribosomal frameshift at the end of Gag translation. Because of the lower efficiency of this frameshift, Gag-Pol is synthesized 20-fold less frequently than Gag.5 The frameshift’s mechanism depends upon a slippery heptanucleotide sequence UUUUUUA and a downstream RNA secondary structure called the frameshift stimulatory signal (FSS).6 This FSS controls the efficiency of the frameshift process.

Page 359 of 2,740First356357358359360361362363Last